2023Q1营收增长1.6%,营业利润下滑1.8%,净利润增长19.2%,
目前市盈率20.6倍,市盈率TTM 19.7倍,和利润增速...查看全文
$犹他医疗产品(UTMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001733614-23-000004 Size: 4 KB 网页链接
$犹他医疗产品(UTMD)$ 144 Report of proposed sale of securities Accession Number: 0001959173-23-001851 Act: 33 Size: 4 KB 网页链接
$犹他医疗产品(UTMD)$ SD Specialized disclosure report Accession Number: 0001096906-23-001202 Act: 34 Size: 13 KB 网页链接
$犹他医疗产品(UTMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001733614-23-000003 Size: 4 KB 网页链接
$犹他医疗产品(UTMD)$ 144 Report of proposed sale of securities Accession Number: 0001949846-23-000088 Act: 33 Size: 3 KB 网页链接
$犹他医疗产品(UTMD)$ 8-K Current report, item 5.07 Accession Number: 0001096906-23-000990 Act: 34 Size: 153 KB 网页链接
$犹他医疗产品(UTMD)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001811884-23-000013 Act: 34 Size: 1 MB 网页链接
$犹他医疗产品(UTMD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001096906-23-000901 Act: 34 Size: 215 KB 网页链接
$犹他医疗产品(UTMD)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001096906-23-000785 Act: 34 Size: 119 KB 网页链接
$犹他医疗产品(UTMD)$ DEF 14A Other definitive proxy statements Accession Number: 0001096906-23-000725 Act: 34 Size: 580 KB 网页链接